Inventor
SANTANGELO FRANCESCO
IT45 patents
⚠️ This page may combine multiple inventors who share the name “SANTANGELO FRANCESCO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ZAMBON SPA
30 patentsUS5196440AMar 23, 1993
Compounds active as inhibitors of the cholesterol biosynthesis
ZAMBON SPA68 citations96
US4940800AJul 10, 1990
Beazimidazole compounds active as inhibitors of the cholesterol biosynthesis
ZAMBON SPA67 citations96
US5739123AApr 14, 1998
Phosphinic acid derivatives with metallopeptidase inhibitory activity
ZAMBON SPA50 citations92
US5468746ANov 21, 1995
Compounds active on the cardiovascular system
ZAMBON SPA36 citations92
US5081136AJan 14, 1992
1,2,3-triazole compounds active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them
ZAMBON SPA62 citations92
US5747513AMay 5, 1998
Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
ZAMBON SPA22 citations91
US6589951B1Jul 8, 2003
Phthalazine derivatives as phosphodiesterase 4 inhibitors
ZAMBON SPA19 citations79
US4983606AJan 8, 1991
Pharmaceutically-active phthalazine compounds
ZAMBON SPA10 citations74
US5426179AJun 20, 1995
Steroid compounds active on the cardiovascular system
ZAMBON SPA7 citations73
US5407956AApr 18, 1995
2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
ZAMBON SPA7 citations72
US5519054AMay 21, 1996
Pharmaceutical compositions containing N-acetyl-cysteine derivatives useful for the treatment of cataract
ZAMBON SPA8 citations71
US6107318AAug 22, 2000
Naphthothiazolone derivatives active on the D3 dopaminergic receptor
ZAMBON SPA9 citations67
US6627659B1Sep 30, 2003
Methods of decreasing the effects of oxidative stress using N-acetylcysteine
ZAMBON SPA4 citations63
US5506259AApr 9, 1996
β-mercapto-propanamide derivatives useful in the treatment of cardiovascular diseases
ZAMBON SPA2 citations63
US5438046AAug 1, 1995
N-heteroaryl substituted derivatives of propanamide useful in the treatment of cardiovascular diseases
ZAMBON SPA4 citations63
US5438047AAug 1, 1995
Diphosphates of catecholamines and pharmaceutical compositions containing them
ZAMBON SPA6 citations63
US5221770AJun 22, 1993
Process for the preparation of 2-amino-5,6-dimethoxy-tetralin
ZAMBON SPA4 citations63
US6548480B1Apr 15, 2003
Phosphonic acid derivatives with metallopeptidase inhibitory activity
ZAMBON SPA3 citations62
US6211380B1Apr 3, 2001
Process for the preparation of heteroaryl-zinc halides
ZAMBON SPA4 citations62
US6166051ADec 26, 2000
Thiol derivatives with metallopeptidase (ACE/NEP) inhibitory activity
ZAMBON SPA2 citations62
US5866604AFeb 2, 1999
Thiol derivatives with metallopeptidase inhibitory activity
ZAMBON SPA6 citations62
US5760241AJun 2, 1998
Thiol derivatives with metallopeptidase inhibitory activity
ZAMBON SPA3 citations62
US6080768AJun 27, 2000
Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
ZAMBON SPA2 citations61
US5451608ASep 19, 1995
2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovasular system, processes for their preparation and pharmaceutical compositions containing them
ZAMBON SPA5 citations61
US5760285AJun 2, 1998
Phosphonyldipeptides useful in the treatment of cardiovascular diseases
ZAMBON SPA1 citations52
US5994539ANov 30, 1999
Mercapto acyl aminoacid derivatives endowed with dual ACE-NEP inhibitory activity, useful in the treatment of cardiovascular diseases
ZAMBON SPA0 citations51
US5716943AFeb 10, 1998
Phosphinic acid derivatives with metallopeptidase inhibitory activity
ZAMBON SPA1 citations51
US6063964AMay 16, 2000
5-hydroxymethyl-2-aminotetralins as cardiovascular agents
ZAMBON SPA0 citations50
US5847092ADec 8, 1998
Erythromycin A 9-0 oxime derivatives endowed with antibiotic activity
ZAMBON SPA0 citations50
US6232348B1May 15, 2001
Hydroxymethyl derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene as cardiovascular agent
ZAMBON SPA0 citations36
SIMES
10 patentsUS5138084AAug 11, 1992
Process for the preparation of 4-o-phosphates of dopamine and dopamine derivatives
SIMES29 citations92
US5073547ADec 17, 1991
Dopamine pro-drug
SIMES43 citations92
US5013753AMay 7, 1991
Prodrugs of dopamine
SIMES19 citations82
US5151414ASep 29, 1992
Phenoxyethyl amine compounds active on the cardiovascular system
SIMES6 citations73
US4988735AJan 29, 1991
Ethylene diamine active cardiovascular therapy
SIMES10 citations69
US4673671AJun 16, 1987
Method for improving the absorption and effectiveness of a catecholamine compound
SIMES5 citations63
US5070106ADec 3, 1991
Compounds active on the cardiovascular system
SIMES4 citations62
US5025011AJun 18, 1991
Fused pyridines active on the cardiovascular system
SIMES2 citations62
US5047425ASep 10, 1991
Amine derivatives having cardiovascular activity
SIMES1 citations46
US5144059ASep 1, 1992
Catecholamine esters
SIMES0 citations42